Literature DB >> 19682614

Chromatin assembly on herpes simplex virus genomes during lytic infection.

Xu Lu1, Steven J Triezenberg.   

Abstract

The human herpes simplex viruses HSV-1 and HSV-2 infect a significant portion of the human population. Both viruses can undergo lytic infection in epithelial cells and establish lifelong latency in neuronal cells. The large HSV-1 DNA genomes have long been considered to be devoid of histones both inside the virion particle and inside the cell during lytic infection, but to be packaged in repressive chromatin during latency. However, recent reports indicate that many histone and non-histone chromosomal proteins can associate with viral DNA during lytic infection and may influence important events during the HSV-1 lytic cycle. In this article, we summarize recent developments in this field and their implications. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19682614      PMCID: PMC2839036          DOI: 10.1016/j.bbagrm.2009.08.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  67 in total

1.  Capsid assembly and DNA packaging in herpes simplex virus.

Authors: 
Journal:  Rev Med Virol       Date:  1997-07       Impact factor: 6.989

Review 2.  Mechanisms for ATP-dependent chromatin remodelling: farewell to the tuna-can octamer?

Authors:  Andrew Flaus; Tom Owen-Hughes
Journal:  Curr Opin Genet Dev       Date:  2004-04       Impact factor: 5.578

Review 3.  Histone variants: deviants?

Authors:  Rohinton T Kamakaka; Sue Biggins
Journal:  Genes Dev       Date:  2005-02-01       Impact factor: 11.361

Review 4.  The histone variant CENP-A and centromere specification.

Authors:  Ben E Black; Emily A Bassett
Journal:  Curr Opin Cell Biol       Date:  2008-01-15       Impact factor: 8.382

5.  Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.

Authors:  Weiqun Shen; Chao Xu; Wei Huang; Jiahai Zhang; Justin E Carlson; Xiaoming Tu; Jihui Wu; Yunyu Shi
Journal:  Biochemistry       Date:  2007-02-03       Impact factor: 3.162

6.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

7.  Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1.

Authors:  Jing Huang; Jennifer R Kent; Brandon Placek; Kelly A Whelan; Charles M Hollow; Ping-Yao Zeng; Nigel W Fraser; Shelley L Berger
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2.

Authors:  K Z Bourne; N Bourne; S F Reising; L R Stanberry
Journal:  Antiviral Res       Date:  1999-07       Impact factor: 5.970

9.  Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement.

Authors:  C L Peterson; A Dingwall; M P Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.

Authors:  Mahavir Singh; Grzegorz M Popowicz; Marcin Krajewski; Tad A Holak
Journal:  Chembiochem       Date:  2007-07-23       Impact factor: 3.164

View more
  12 in total

1.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

2.  Uncoupling uncoating of herpes simplex virus genomes from their nuclear import and gene expression.

Authors:  Kathrin Rode; Katinka Döhner; Anne Binz; Mandy Glass; Tanja Strive; Rudolf Bauerfeind; Beate Sodeik
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

3.  Herpes simplex virus 1 DNA is in unstable nucleosomes throughout the lytic infection cycle, and the instability of the nucleosomes is independent of DNA replication.

Authors:  Jonathan J Lacasse; Luis M Schang
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

4.  Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.

Authors:  Takayuki Murata; Yutaka Kondo; Atsuko Sugimoto; Daisuke Kawashima; Shinichi Saito; Hiroki Isomura; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

5.  Early nucleosome deposition on, and replication of, HSV DNA requires cell factor PCNA.

Authors:  Iryna Sanders; Mark Boyer; Nigel W Fraser
Journal:  J Neurovirol       Date:  2015-02-12       Impact factor: 2.643

6.  Fragment Size-Based Enrichment of Viral Sequences in Plasma Cell-Free DNA.

Authors:  Quynh Phung; Michelle J Lin; Hong Xie; Alexander L Greninger
Journal:  J Mol Diagn       Date:  2022-02-22       Impact factor: 5.341

7.  Detection of the genome and transcripts of a persistent DNA virus in neuronal tissues by fluorescent in situ hybridization combined with immunostaining.

Authors:  Frédéric Catez; Antoine Rousseau; Marc Labetoulle; Patrick Lomonte
Journal:  J Vis Exp       Date:  2014-01-23       Impact factor: 1.355

8.  Chromatin assembly on herpes simplex virus 1 DNA early during a lytic infection is Asf1a dependent.

Authors:  Jaewook Oh; Nicholas Ruskoski; Nigel W Fraser
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

9.  Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection.

Authors:  Wali Hafezi; Eva U Lorentzen; Bodo R Eing; Marcus Müller; Nicholas J C King; Barbara Klupp; Thomas C Mettenleiter; Joachim E Kühn
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

10.  An Essential Viral Transcription Activator Modulates Chromatin Dynamics.

Authors:  Rebecca L Gibeault; Kristen L Conn; Michael D Bildersheim; Luis M Schang
Journal:  PLoS Pathog       Date:  2016-08-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.